archive-sg.com » SG » S » SINGAPOREONCOLOGY.COM.SG

Total: 19

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Contact Us | Singapore Oncology Consultants
    64750068 SOC Gleneagles 6 Napier Road 05 11 12 Gleneagles Medical Centre Singapore 258499 Tel 65 6471 3373 Fax 65 6471 1062 SOC Palliative Care 3 Mount Elizabeth 17 03 05 Mt Elizabeth Medical Centre Singapore 228510 Tel 65 6737 8000 Fax 65 6737 9149 Email Us Your Name required Your Email required Your Mobile Phone Your Home Phone Subject Your Message Singapore Oncology Consultants Our Mission is to provide

    Original URL path: http://singaporeoncology.com.sg/contact/ (2013-01-30)
    Open archived version from archive

  • Head and Neck Cancer : Are You at Risk? | Singapore Oncology Consultants
    of developing squamous cell carcinomas of the mouth Recently human papilloma virus HPV the virus which causes cervical cancer has been found in up to 60 of the squamous cell cancers of the mouth and tongue In most people who develop thyroid cancer the cause is unknown Radiation exposure to the neck or inherited genetic predisposition increases the risk in only a minority of patients Women are three times as likely to develop thyroid cancer as men Symptoms and Screening Symptoms of NPC include headaches hearing loss especially in one ear only nasal stuffiness facial pain nosebleeds difficulty opening the mouth blurred or double vision and a lump in the neck area Symptoms of HNSCC include a change in the voice difficulty in or pain with swallowing blood in the sputum a growth or an ulcer that does not heal in the mouth or tongue or a lump in the neck Symptoms of thyroid cancer include a lump in the front of the neck near the Adam s apple difficulty swallowing or breathing a lump in the side of the neck pain in the neck or throat and voice changes Thyroid Cancers are also increasingly more often found incidentally when ultrasounds or CT scans are done for other reasons Because of the fact that many of these symptoms are not specific for cancer many patients ignore these symptoms or are treated for other problems such as infections for long periods of times before the correct diagnosis is made As a result many of the patients who are diagnosed with head and neck cancers are diagnosed with late stage disease People with the symptoms listed above should seek prompt medical evaluation and treatment especially if they belong to the high risk groups for developing these cancers People with early forms of these cancers often do not have any symptoms Although there are no accepted methods of routine screening for early detection of head and neck cancers certain measures may be helpful For example careful examination of the mouth and tongue during routine dental treatments can help to find abnormal areas which may be cancerous Studies in Hong Kong and Singapore have shown that routine examinations of the back of the nose by an Ear Nose and Throat Specialist ENT can pick up NPC at an earlier stage However it is not clear who should undergo such routine examinations and how often Currently the most helpful way of diagnosing head and neck cancer early is still prompt evaluation of any suspicious symptoms which do not improve or resolve after 2 to 3 weeks Diagnosis Diagnosis of head and neck cancers are made by careful examinations of the area which is affected and doing a biopsy of the area The examination of the nose mouth and throat area is done with fibro optic scope which is a flexible tube with a camera on the end that allows the specialist to see areas inside the body Diagnosis also involves CT scan Magnetic Resonance Imaging

    Original URL path: http://singaporeoncology.com.sg/head-and-neck-cancer-are-you-at-risk/ (2013-01-30)
    Open archived version from archive

  • Cancer of the Bones | Singapore Oncology Consultants
    that can show up certain changes in the bone and may show that a secondary bone cancer is present A cancer of the bone may not always show up on a plain bone x ray c bone scan is a more sensitive test than a simple x ray and shows up any abnormal areas of bone more clearly A small amount of a mildly radioactive substance is injected into a vein usually in your arm Abnormal bone absorbs more radioactivity than normal bone so these areas are highlighted and picked up by the scanner as hot spots The level of radioactivity used in the scan is very small and does not cause any harm to your body d CT computerised tomography scan takes a series of x rays which build up a three dimensional 3D picture of the inside of the body e MRI magnetic resonance imaging scan is similar to a CT scan but uses magnetic fields instead of x rays to build up a series of cross sectional pictures of the body f PET positron emission tomography CT scan uses low dose radioactive glucose a type of sugar to measure the activity of cells in different parts of the body together with CT scan Before the scan a very small amount of a mildly radioactive substance is injected into a vein usually in your arm Areas of cancer are usually more active than surrounding tissue and show up on the scan g Biopsy is the removal of a small amount of tissue for examination under microscope Only a biopsy can make a definite diagnosis of cancer in the bone The sample removed from the biopsy is analyzed by a pathologist doctor who specializing interpreting laboratory tests and evaluating cells tissues and organs to diagnose disease The type of biopsy needle or open incisional perform will depend on the location of the cancer However there are some cases where a biopsy may not be able to perform If a Secondary Bone Cancer is Found Before the Primary Cancer y0ur doctor may arrange for you to have tests to find where the primary cancer is in your body Such tests may include mammogram to look for primary cancer in the breast a chest x ray and CT scan to check for lung cancer a CT or ultrasound scan of abdomen and pelvis to look for kidney cancer or a prostate ultrasound and blood sample to check for prostate cancer Treatment of Secondary Bone Cancer A number of different types of treatment can be used to treat people with secondary bone cancer The treatment you have will depend on which bone is affected where the cancer first started the primary cancer how damaged and weakened the bone is and how the cancer is affecting you the symptoms you have size of the tumour and your overall health It is often a team of doctors will work with you to determine the best treatment plan The aim of treatment for a secondary

    Original URL path: http://singaporeoncology.com.sg/cancer-of-the-bone-what-must-i-do/ (2013-01-30)
    Open archived version from archive

  • Soy and Breast Cancer | Singapore Oncology Consultants
    43 with 5 years follow up Other studies on soy and breast cancer survivors were reported both in US and China A US study on a cohort of 1 954 breast cancer patients were prospectively followed up for 6 years Increasing quintiles of soy intakes was associated with lower breast cancer recurrence compared to no intake among postmenopausal women and among Tamoxifen users They concluded that soy isoflavones consumed at levels comparable to those in Asian populations may reduce the risk of cancer recurrence in survivors even with Tamoxifen therapy Moreover soy does not appear to interfere with Tamoxifen efficacy The most recent Shanghai Breast Cancer Survival Study reported a cohort of 5 042 breast cancer survivors in China in Oct 2009 aged 20 to 75 years old With 4 years follow up they reported the findings of an inverse correlation on mortality and recurrence among highest and lowest quartile of soy intake Relative risk of 29 for mortality and 32 for recurrence The inverse association was evident among women with either estrogen receptor positive or negative breast cancer as well as both users and nonusers of Tamoxifen in death and recurrence They also observed that women not taking Tamoxifen who ate the most soy seemed to have a better prognosis than women who took Tamoxifen and ate the least soy The associations did not vary by menopausal status cancer stage estrogen receptors of the breast cancer or intake of Tamoxifen Of significance the high soy protein intakes in this study were more than 15 3 mg of soy protein or more than 62 3 mg of isoflavones The relationship between soy and breast cancer is complicated by other factors Most women living in Asia depend on soy as their main source of protein They consume only small amounts of

    Original URL path: http://singaporeoncology.com.sg/soy-and-breast-cancer/ (2013-01-30)
    Open archived version from archive

  • Dr Florence Lim | Singapore Oncology Consultants
    on Roll of Specialists International Medicine Singapore in 1991 She trained in Ludwig Institute of Cancer Research Sydney Australia She has served in a number of committees including as chairman of the Scientific Committee for Hospice Care Update Council Member of the Hospice Care Association Vice Chairman of the Singapore Nursing Board Education for the Post Basic Oncology Nursing Course She is also a Committee Member for Pediatric Medical Oncology Course and Internal Medicine Representative to Medical Advisory Board Mt Elizabeth Hospital and in the committee of Asia Pacific Congress of Cancer 1995 She has volunteered with the Medical Relief Team for Mt Pinatubo disaster in the Philippines in 1992 Dr Lim has also published in peer reviewed journals on subjects ranging from the use of various chemotherapy drugs on different types of cancer management of side effects of chemotherapy Neurological Complications of Undifferentiated High Grade Lymphoma and the use of Targeted Therapy in Cancer Research Cancer Interest Cancer Chemotherapy Head and Neck Tumors Colon Breast and Gynecological cancers Patient Care Treatment Diagnosis of Adult Cancers and Cancer Counseling Singapore Oncology Consultants Our Mission is to provide quality cancer treatment at an affordable cost through the latest innovations in cancer

    Original URL path: http://singaporeoncology.com.sg/our-consultants/dr-florence-lim/ (2013-01-30)
    Open archived version from archive

  • Dr Karmen Wong | Singapore Oncology Consultants
    in other cancers with different disciplines of doctors Dr Wong also initiated the bone marrow transplant programme in solid tumour in Singapore in 1997 She spearheaded the multi disciplinary tumour board and Breast Cancer Clinic in Singapore General Hospital Dr Wong presented the 1 st Asian study in attitudes of cancer treatment among Asian patients in the Annual Meeting of the American Society of Clinical Oncology in 1999 She has also written peer review articles and published chapters in textbooks Her sub specialty interests are in cancer chemotherapy in breast gastro intestinal lung and HIV related cancers Credentials Granted the status of Fellow to the Academy of Medicine in Singapore in 1994 Certified with the Singapore Medical Council the Medical Board of South Australia the Medical Board of Victoria Australia the General Medical Council of UK and the Hong Kong Medical Council Member of the American Society of Medical Oncology the Singapore Oncology Society Specialist accreditation in Medical Oncology with the Singapore Ministry of Health Member of the International Breast Cancer Study Group Committee member of Breast Cancer Foundation Singapore Research Cancer Interest Sub specialty Cancer Chemotherapy Soft Tissue Tumors Breast and HIV related cancers Patient Care Treatment Diagnosis of

    Original URL path: http://singaporeoncology.com.sg/our-consultants/dr-karmen-wong/ (2013-01-30)
    Open archived version from archive

  • Dr Yap-Whang Hwee Yong | Singapore Oncology Consultants
    been a member of the American Association of Cancer Research and American Society of Clinical Oncology since 1977 In 1984 she was elected as a fellow to the Board of American College of Physicians and also became a member of the Academy of Medicine Singapore While as a faculty member in the Department of Medicine at MD Anderson Cancer Center Dr Yap Whang was involved in many research activities and was the principal investigator for Phase 1 II developmental therapeutics and other research protocols for the treatment of breast cancer brain tumors and CNS metastases In addition to her more than sixty publications in international and American Peer Review Journals she was invited as speaker in many international European and American medical meetings and seminars Throughout her tenure at MD Anderson Cancer Center her yearly abstracts were all selected for oral presentations at both ASCO and AACR meetings Since her return to Singapore Dr Yap Whang continues to be active in her participation of European and American Oncology meetings and seminars She was also involved in the selection and referral of patients for various clinical research activities both locally and oversea Research Cancer Interest Sub specialty Cancer Chemotherapy and Clinical

    Original URL path: http://singaporeoncology.com.sg/our-consultants/dr-yap-whang/ (2013-01-30)
    Open archived version from archive

  • Prof Tan Yew Oo | Singapore Oncology Consultants
    at Singapore General Hospital and later National University Hospital He has been the mentor and teacher to many doctors including many prominent medical oncologists in Singapore He published extensively and was invited to speak at regional and international medical meetings He continues to be invited to lecture at many local and regional medical conferences and seminars After he went into private practice he remained active in medical education and postgraduate training He served in the Specialist Training Committee of Medical Oncology Academy of Medicine MOH Singapore Chairman of the National Committee on Cancer Care Medical Research Council and consultant to the Health Science Authority He was examiner in Master of Medicine M Med and sat on Board of Directors of Singapore Health Services from 2000 till 2006 He remains active in clinical cancer research and he continues to participate in Phase III clinical trials on novel anti cancer agents He enrolled patients in several international phase III clinical trials using PTK 787 in Confirm 1 lapatinib in breast cancer IPASS in NSCLC with Iressa and E7389 in breast cancer He is recruiting patients for several ongoing trials using Neratinib in breast cancer oral talactoferrin in lung cancer and nimotumumab in

    Original URL path: http://singaporeoncology.com.sg/our-consultants/prof-tan-yo/ (2013-01-30)
    Open archived version from archive